IGF2BP2, overexpressed in pancreatic cancer tissues, boosts pancreatic cancer cells’ growth through the activation of the PI3K/Akt signaling pathway in vitro and in vivo [42]. Here, AKT1 is linked to familial pancreatic carcinoma.